{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:42:27Z","timestamp":1793108547367,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Pa 611\/5-3"],"award-info":[{"award-number":["Pa 611\/5-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Pa 611\/ 9-2"],"award-info":[{"award-number":["Pa 611\/ 9-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Pa 611\/ 11-1"],"award-info":[{"award-number":["Pa 611\/ 11-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PE 3217\/4-1"],"award-info":[{"award-number":["PE 3217\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PE 3217\/2-1"],"award-info":[{"award-number":["PE 3217\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2020_EKFK.15"],"award-info":[{"award-number":["2020_EKFK.15"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2021-EKEA.111"],"award-info":[{"award-number":["2021-EKEA.111"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2021_EKEA.122"],"award-info":[{"award-number":["2021_EKEA.122"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Elevated activity of transcription factor NFE2 is sufficient to cause leukemic transformation in absence of a classical leukemic driver. However, the molecular mechanism promoting NFE2-driven leukemogenesis is not known. Here we report a previously unrecognized role for NFE2 as a key regulator of the oxidative stress response in leukemic cells. Through a comprehensive analysis of NFE2 genomic occupancy and its effect on chromatin accessibility and transcription, we demonstrate that NFE2 regulates glutathione homeostasis as well as the expression of central detoxifying enzymes. NFE2 constituted one of the highest scoring gene dependencies in MLL-AF9-transformed primary leukemic cells under redox stress, substantially more significant than the universally recognized redox regulator NRF2. Consequently, NFE2 knockdown sensitized leukemic cells to GSH depletion, ferroptosis induction, as well as to cytarabine treatment. Deriving an NFE2 RedOx score, we demonstrate that increased NFE2 activity constitutes an independent predictor of inferior outcome in AML patients at diagnosis.<\/jats:p>","DOI":"10.1038\/s41375-026-03095-x","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:13:40Z","timestamp":1787138020000},"page":"2481-2493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel role for transcription factor NFE2 in redox regulation and chemotherapy resistance in acute myeloid leukemia"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7977-0121","authenticated-orcid":false,"given":"Anne Marie","family":"Staehle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-3321","authenticated-orcid":false,"given":"Florian","family":"Perner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5082-0646","authenticated-orcid":false,"given":"Hans Felix","family":"Staehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Gellrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6355-0622","authenticated-orcid":false,"given":"Fiona","family":"Prei\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5436-712X","authenticated-orcid":false,"given":"Annika","family":"Grafemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1682-4487","authenticated-orcid":false,"given":"Jana","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luca","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Gr\u00fcnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Berner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Bekeschus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9919-7852","authenticated-orcid":false,"given":"Christoph","family":"Koellerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2857-2396","authenticated-orcid":false,"given":"Heike L.","family":"Pahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"3095_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1182\/blood-2009-11-254664","volume":"116","author":"W Wang","year":"2010","unstructured":"Wang W, Schwemmers S, Hexner EO, Pahl HL. AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2. Blood. 2010;116:254\u201366.","journal-title":"Blood"},{"key":"3095_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1365-2141.2005.05416.x","volume":"129","author":"PS Goerttler","year":"2005","unstructured":"Goerttler PS, Kreutz C, Donauer J, Faller D, Maiwald T, M\u00e4rz E, et al. Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2. Br J Haematol. 2005;129:138\u201350.","journal-title":"Br J Haematol"},{"key":"3095_CR3","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1084\/jem.20120521","volume":"210","author":"JS Jutzi","year":"2013","unstructured":"Jutzi JS, Bogeska R, Nikoloski G, Schmid CA, Seeger TS, Stegelmann F, et al. MPN patients harbor recurrent truncating mutations in transcription factor NF-E2. J Exp Med. 2013;210:1003\u201319.","journal-title":"J Exp Med"},{"key":"3095_CR4","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1182\/blood-2018-09-875047","volume":"133","author":"JS Jutzi","year":"2019","unstructured":"Jutzi JS, Basu T, Pellmann M, Kaiser S, Steinemann D, Sanders MA, et al. Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations. Blood. 2019;133:1766\u201377.","journal-title":"Blood"},{"key":"3095_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.20110540","volume":"209","author":"KB Kaufmann","year":"2012","unstructured":"Kaufmann KB, Gr\u00fcnder A, Hadlich T, Wehrle J, Gothwal M, Bogeska R, et al. A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2. J Exp Med. 2012;209:35\u201350.","journal-title":"J Exp Med"},{"key":"3095_CR6","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1182\/blood.2020010402","volume":"138","author":"Marcault","year":"2021","unstructured":"Marcault, Zhao C, Maslah L-P, Verger N, Daltro de Oliveira R E, Soret-Dulphy J, et al. Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms. Blood. 2021;138:2142\u20138.","journal-title":"Blood"},{"key":"3095_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-025-01145-0","volume":"24","author":"DD Zhang","year":"2025","unstructured":"Zhang DD. Thirty years of NRF2: advances and therapeutic challenges. Nat Rev Drug Discov. 2025;24:421\u201344.","journal-title":"Nat Rev Drug Discov"},{"key":"3095_CR8","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1182\/blood-2012-04-422121","volume":"120","author":"SA Rushworth","year":"2012","unstructured":"Rushworth SA, Zaitseva L, Murray MY, Shah NM, Bowles KM, MacEwan DJ. The high Nrf2 expression in human acute myeloid leukemia is driven by NF-\u03baB and underlies its chemo-resistance. Blood. 2012;120:5188\u201398.","journal-title":"Blood"},{"key":"3095_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature04980","volume":"442","author":"AV Krivtsov","year":"2006","unstructured":"Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature. 2006;442:818\u201322.","journal-title":"Nature"},{"key":"3095_CR10","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gkv1495","volume":"44","author":"L Arrigoni","year":"2016","unstructured":"Arrigoni L, Richter AS, Betancourt E, Bruder K, Diehl S, Manke T, et al. Standardizing chromatin research: a simple and universal method for ChIP-seq. Nucleic Acids Res. 2016;44:e67.","journal-title":"Nucleic Acids Res"},{"key":"3095_CR11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods. 2017;14:959\u201362.","journal-title":"Nat Methods"},{"key":"3095_CR12","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","volume":"40","author":"D Bottomly","year":"2022","unstructured":"Bottomly D, Long N, Schultz AR, Kurtz SE, Tognon CE, Johnson K, et al. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia. Cancer Cell. 2022;40:850\u201364.e9.","journal-title":"Cancer Cell"},{"key":"3095_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nm.4439","volume":"24","author":"H Bolouri","year":"2018","unstructured":"Bolouri H, Farrar JE, Triche T, Ries RE, Lim EL, Alonzo TA, et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat Med. 2018;24:103\u201312.","journal-title":"Nat Med"},{"key":"3095_CR14","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059\u201374.","DOI":"10.1056\/NEJMoa1301689"},{"key":"3095_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3324\/haematol.13299","volume":"94","author":"RGW Verhaak","year":"2009","unstructured":"Verhaak RGW, Wouters BJ, Erpelinck CAJ, Abbas S, Beverloo HB, Lugthart S, et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica. 2009;94:131\u20134.","journal-title":"Haematologica"},{"key":"3095_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ccell.2022.02.006","volume":"40","author":"AK Jayavelu","year":"2022","unstructured":"Jayavelu AK, Wolf S, Buettner F, Alexe G, H\u00e4upl B, Comoglio F, et al. The proteogenomic subtypes of acute myeloid leukemia. Cancer Cell. 2022;40:301\u201317.e12.","journal-title":"Cancer Cell"},{"key":"3095_CR17","doi-asserted-by":"publisher","first-page":"8398","DOI":"10.1073\/pnas.91.18.8398","volume":"91","author":"SJ Lu","year":"1994","unstructured":"Lu SJ, Rowan S, Bani MR, Ben-David Y. Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin expression. Proc Natl Acad Sci USA 1994;91:8398\u2013402.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3095_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/120305","volume":"2013","author":"MR Campbell","year":"2013","unstructured":"Campbell MR, Karaca M, Adamski KN, Chorley BN, Wang X, Bell DA. Novel hematopoietic target genes in the NRF2-mediated transcriptional pathway. Oxid Med Cell Longev. 2013;2013:120305.","journal-title":"Oxid Med Cell Longev"},{"key":"3095_CR19","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1038\/s44319-025-00463-z","volume":"26","author":"RJ Conrad","year":"2025","unstructured":"Conrad RJ, Mondo JA, Wang ML, Liu PS, Lai Z, Choudhury FK, et al. NRF2 supports non-small cell lung cancer growth independently of CBP\/p300-enhanced glutathione synthesis. EMBO Rep. 2025;26:3106\u201337.","journal-title":"EMBO Rep"},{"key":"3095_CR20","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/j.celrep.2016.08.010","volume":"16","author":"LD Goldstein","year":"2016","unstructured":"Goldstein LD, Lee J, Gnad F, Klijn C, Schaub A, Reeder J, et al. Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers. Cell Rep. 2016;16:2605\u201317.","journal-title":"Cell Rep"},{"key":"3095_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1182\/blood-2009-05-223107","volume":"115","author":"H Motohashi","year":"2010","unstructured":"Motohashi H, Kimura M, Fujita R, Inoue A, Pan X, Takayama M, et al. NF-E2 domination over Nrf2 promotes ROS accumulation and megakaryocytic maturation. Blood. 2010;115:677\u201386.","journal-title":"Blood"},{"key":"3095_CR22","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202318014","volume":"15","author":"H Alborzinia","year":"2023","unstructured":"Alborzinia H, Chen Z, Yildiz U, Freitas FP, Vogel FCE, Varga JP, et al. LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma. EMBO Mol Med. 2023;15:e18014.","journal-title":"EMBO Mol Med"},{"key":"3095_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28242-7","volume":"13","author":"C Umansky","year":"2022","unstructured":"Umansky C, Morellato AE, Rieckher M, Scheidegger MA, Martinefski MR, Fern\u00e1ndez GA, et al. Endogenous formaldehyde scavenges cellular glutathione resulting in redox disruption and cytotoxicity. Nat Commun. 2022;13:745.","journal-title":"Nat Commun"},{"key":"3095_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2020.128701","volume":"269","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Wei L, Tagmount A, Loguinov A, Sobh A, Hubbard A, et al. Applying genome-wide CRISPR to identify known and novel genes and pathways that modulate formaldehyde toxicity. Chemosphere. 2021;269:128701.","journal-title":"Chemosphere"},{"key":"3095_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1089\/ars.2024.0882","volume":"42","author":"B Fan","year":"2025","unstructured":"Fan B, Wang L, Hu T, Zheng L, Wang J. Exosomal miR-196a-5p Secreted by Bone Marrow Mesenchymal Stem Cells Inhibits Ferroptosis and Promotes Drug Resistance of Acute Myeloid Leukemia. Antioxid Redox Signal. 2025;42:933\u201353.","journal-title":"Antioxid Redox Signal"},{"key":"3095_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2008.03.036","volume":"270","author":"A Sallmyr","year":"2008","unstructured":"Sallmyr A, Fan J, Rassool FV. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair. Cancer Lett. 2008;270:1\u20139.","journal-title":"Cancer Lett"},{"key":"3095_CR27","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood-2007-05-092510","volume":"111","author":"A Sallmyr","year":"2008","unstructured":"Sallmyr A, Fan J, Datta K, Kim K-T, Grosu D, Shapiro P, et al. Internal tandem duplication of FLT3 (FLT3\/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML. Blood. 2008;111:3173\u201382.","journal-title":"Blood"},{"key":"3095_CR28","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1182\/blood-2013-04-491944","volume":"122","author":"PS Hole","year":"2013","unstructured":"Hole PS, Zabkiewicz J, Munje C, Newton Z, Pearn L, White P, et al. Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling. Blood. 2013;122:3322\u201330.","journal-title":"Blood"},{"key":"3095_CR29","doi-asserted-by":"publisher","first-page":"33542","DOI":"10.1074\/jbc.M113.511170","volume":"288","author":"S Pei","year":"2013","unstructured":"Pei S, Minhajuddin M, Callahan KP, Balys M, Ashton JM, Neering SJ, et al. Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells. J Biol Chem. 2013;288:33542\u201358.","journal-title":"J Biol Chem"},{"key":"3095_CR30","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.exphem.2016.08.008","volume":"44","author":"AK Jayavelu","year":"2016","unstructured":"Jayavelu AK, Moloney JN, B\u00f6hmer F-D, Cotter TG. NOX-driven ROS formation in cell transformation of FLT3-ITD-positive AML. Exp Hematol. 2016;44:1113\u201322.","journal-title":"Exp Hematol"},{"key":"3095_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-03012-9","volume":"42","author":"DM Mathew","year":"2025","unstructured":"Mathew DM, Gopalakrishnan AV. Targeting Nrf2 in acute myeloid leukemia: an updated review on its role in chemoresistance and emerging therapeutic strategies. Med Oncol. 2025;42:460.","journal-title":"Med Oncol"},{"key":"3095_CR32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.exphem.2016.04.012","volume":"44","author":"U Testa","year":"2016","unstructured":"Testa U, Labbaye C, Castelli G, Pelosi E. Oxidative stress and hypoxia in normal and leukemic stem cells. Exp Hematol. 2016;44:540\u201360.","journal-title":"Exp Hematol"},{"key":"3095_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41375-023-02117-2","volume":"38","author":"H Akiyama","year":"2024","unstructured":"Akiyama H, Zhao R, Ostermann LB, Li Z, Tcheng M, Yazdani SJ, et al. Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia. Leukemia. 2024;38:729\u201340.","journal-title":"Leukemia"},{"key":"3095_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1182\/bloodadvances.2023010786","volume":"8","author":"A Cunningham","year":"2024","unstructured":"Cunningham A, Oudejans LL, Geugien M, Pereira-Martins DA, Wierenga ATJ, Erdem A, et al. The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia. Blood Adv. 2024;8:56\u201369.","journal-title":"Blood Adv"},{"key":"3095_CR35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2210796120","volume":"120","author":"D Huang","year":"2023","unstructured":"Huang D, Zhang C, Xiao M, Li X, Chen W, Jiang Y, et al. Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells. Proc Natl Acad Sci USA 2023;120:e2210796120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3095_CR36","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1158\/1078-0432.CCR-18-3223","volume":"25","author":"MA Gregory","year":"2019","unstructured":"Gregory MA, Nemkov T, Park HJ, Zaberezhnyy V, Gehrke S, Adane B, et al. Targeting Glutamine Metabolism and Redox State for Leukemia Therapy. Clin Cancer Res. 2019;25:4079\u201390.","journal-title":"Clin Cancer Res"},{"key":"3095_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02574-6","volume":"22","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang X, Feng H, Li X, Yang R, Zhang M, et al. Glutathione-depleting liposome adjuvant for augmenting the efficacy of a glutathione covalent inhibitor oridonin for acute myeloid leukemia therapy. J Nanobiotechnology. 2024;22:299.","journal-title":"J Nanobiotechnology"},{"key":"3095_CR38","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/s41375-022-01573-6","volume":"36","author":"B Pardieu","year":"2022","unstructured":"Pardieu B, Pasanisi J, Ling F, Dal Bello R, Penneroux J, Su A, et al. Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia. Leukemia. 2022;36:1585\u201395.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03095-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03095-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03095-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:59:00Z","timestamp":1793105940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03095-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3095"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03095-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}